SOCS2 deficiency results in constitutive STAT6 activation, enhanced IL-2–mediated STAT5 activation, and reduced IL-6–mediated STAT3 activation. (A) CD4+ splenocytes from WT mice were cultured with anti-CD3 and anti-CD28 in the presence of 20 ng/ml IL-4, 200 U/ml IL-6, 20 ng/ml IL-12, or 5 ng/ml TGF-β for the indicated times. Cells were then lysed and immunoblotted for the expression of SOCS2 and γ-tubulin. (B) CD4+ splenocytes were cultured with anti-CD3 and anti-CD28 for 48 h. 200 ng/ml IL-4 was then added to the culture for times indicated. Cell were lysed and immunoblotted for phospho-STAT6. (C) After 48 h and preactivation with anti-CD3, anti-CD28, 5 ng/ml TGF-β, and 5 U/ml IL-2, CD4+ splenocytes were incubated for 2 h in serum-free media, restimulated with 100 U/ml IL-2 for the indicated times, and immunoblotted for phospho-STAT5. (D and E) CD4+ splenocytes were preactivated for 48 h with anti-CD3 and anti-CD28, rested 2 h in serum-free media, and restimulated with 50 ng/ml IL-12 (D) or 50 U/ml IL-6 (E) for the indicated times, lysed, and immunoblotted for phospho-STAT4 (D) or phospho-STAT3 (E). Total STAT6, STAT5, STAT4, or STAT3 expression was also assessed. Right panels show densitometry of phospho-STAT relative to total STAT. Data are mean and SEM from triplicates. *, P < 0.05; **, P < 0.01; ***, P < 0.001. The data are representative of three independent experiments.